Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: A randomised double-blind, placebo-controlled trial

The Lancet Respiratory Medicine

Volumn 4, Issue 1, 2016, Pages 27-36

  Maddocks, Matthew ^a   Nolan, Claire M ^b,c   Man, William D C ^b,c   Polkey, Michael I ^b   Hart, Nicholas ^a,d   Gao, Wei ^a   Rafferty, Gerrard F ^a   Moxham, John ^a   Higginson, Irene J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c HAREFIELD HOSPITAL   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

6-MIN WALK TEST; ADHESIVE ELECTRODE; ADULT; AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DYSPNEA; ELECTRODE; ERYTHEMA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STIMULATOR; MUSCLE STRENGTH; NATIONAL HEALTH SERVICE; NEUROMUSCULAR ELECTRICAL STIMULATION; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; UNITED KINGDOM; ELECTROTHERAPY; EXERCISE TEST; EXERCISE TOLERANCE; KINESIOTHERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; DYSPNEA; ELECTRIC STIMULATION THERAPY; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84952980747     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00503-2     Document Type: Article

References (43)

1. Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013, 310:591-608.
2. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD 2012, 9:131-141.
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
4. Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012, 40:1115-1122.
5. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007, 62:115-120.
6. Polkey MI, Spruit MA, Edwards LD, et al. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013, 187:382-386.
7. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997, 10:417-423.
8. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015, 2. CD003793.
9. Spruit MA, Singh SJ, Garvey C, et al. An Official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013, 188:e13-e64.
10. Jones SE, Green SA, Clark AL, et al. Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax 2014, 69:181-182.
11. Hogg L, Garrod R, Thornton H, McDonnell L, Bellas H, White P Effectiveness, attendance, and completion of an integrated, system-wide pulmonary rehabilitation service for COPD: prospective observational study. COPD 2012, 9:546-554.
12. Maddocks M, Gao W, Higginson IJ, Wilcock A Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev 2013, 1. CD009419.
13. Sillen MJ, Franssen FM, Vaes AW, Delbressine JM, Wouters EF, Spruit MA Metabolic load during strength training or NMES in individuals with COPD: results from the DICES trial. BMC Pulm Med 2014, 14:146.
14. Sillen MJH, Franssen FME, Delbressine JML, Vaes AW, Wouters EFM, Spruit MA Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial. Thorax 2014, 69:525-531.
15. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ 1959, 2:257-266.
16. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.
17. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014, 44:1428-1446.
18. Polkey MI, Kyroussis D, Hamnegard CH, Mills GH, Green M, Moxham J Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 1996, 19:549-555.
19. Man WD, Hopkinson NS, Harraf F, Nikoletou D, Polkey MI, Moxham J Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease. Thorax 2005, 60:718-722.
20. Seymour J, Spruit M, Hopkinson N, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010, 36:81-88.
21. Seymour JM, Ward K, Sidhu PS, et al. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax 2009, 64:418-423.
22. Steiner MC, Barton RL, Singh SJ, Morgan MD Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002, 19:626-631.
23. Maddocks M, Petrou A, Skipper L, Wilcock A Validity of three accelerometers during treadmill walking and motor vehicle travel. Br J Sports Med 2010, 44:606-608.
24. Rabin R, de Charro F EQ-5D: a measure of health status from the EuroQol Group. Ann Mede 2001, 33:337-343.
25. Jones PW, Quirk FH, Baveystock CM The St George's Respiratory Questionnaire. Respir Med 1991, 85B:25-31.
26. Higginson IJ, Bausewein C, Reilly CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2014, 2:979-987.
27. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997, 155:1278-1282.
28. Bourjeily-Habr G, Rochester CL, Palermo F, Snyder P, Mohsenin V Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax 2002, 57:1045-1049.
29. Little RJ, D'Agostino R, Cohen ML, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med 2012, 367:1355-1360.
30. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009, 338:b2393.
31. Singh SJ, Puhan MA, Andrianopoulos V, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014, 44:1447-1478.
32. Vivodtzev I, Debigare R, Gagnon P, et al. Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest 2012, 141:716-725.
33. Zanotti E, Felicetti G, Maini M, Fracchia C Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest 2003, 124:292-296.
34. Tasdemir F, Inal-Ince D, Ergun P, et al. Neuromuscular electrical stimulation as an adjunct to endurance and resistance training during pulmonary rehabilitation in stable chronic obstructive pulmonary disease. Expert Rev Respir Med 2015, 9:493-502.
35. Steiner MC, Singh SJ, Morgan MD The contribution of peripheral muscle function to shuttle walking performance in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005, 25:43-49.
36. Man WD, Soliman MG, Gearing J, et al. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 168:562-567.
37. Jones NL, Killian KJ Exercise limitation in health and disease. N Engl J Med 2000, 343:632-641.
38. Menon MK, Houchen L, Harrison S, Singh SJ, Morgan MD, Steiner MC Ultrasound assessment of lower limb muscle mass in response to resistance training in COPD. Respir Res 2012, 13:119.
39. Greening NJ, Harvey-Dunstan TC, Chaplin EJ, et al. Bedside assessment of quadriceps muscle using ultrasound following admission for acute exacerbations of chronic respiratory disease. Am J Respir Crit Care Med 2015, 192:810-816.
40. Canavan JL, Maddocks M, Nolan CM, et al. Functionally relevant cut point for isometric quadriceps muscle strength in chronic respiratory disease. Am J Respir Crit Care Med 2015, 192:395-397.
41. Banerjee P, Caulfield B, Crowe L, Clark A Prolonged electrical muscle stimulation exercise improves strength and aerobic capacity in healthy sedentary adults. J Appl Physiol 2005, 99:2307-2311.
42. Greening NJ, Williams JEA, Hussain SF, et al. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial. BMJ 2014, 349:g4315.
43. Maddocks M, Kon SS, Singh SJ, Man WD Rehabilitation following hospitalization in patients with COPD: can it reduce readmissions?. Respirology 2015, 20:395-404.